Form 4: TransDigm Director Exercises Options, Sells Shares

TransDigm Group Director Kevin M. Stein exercised stock options and subsequently sold an equal number of shares through a pre-arranged 10b5-1 plan.

Summary

• Kevin M. Stein, a Director of TransDigm Group INC (TDG), reported transactions involving the company's common stock.
• On November 28, 2025, Mr. Stein exercised stock options to acquire 4,592 shares of common stock at an exercise price of $105.88 per share.
• The exercise price was adjusted for dividends declared since August 1, 2022.
• Immediately following the option exercise, Mr. Stein sold a total of 4,592 shares of common stock in multiple transactions.
• The sales occurred at weighted average prices ranging from $1,360.4385 to $1,362.431 per share.
• These transactions were conducted pursuant to a Rule 10b5-1 trading plan, indicating they were pre-scheduled.
• All shares involved in these transactions are beneficially owned indirectly through the Fortuna Trust dated June 1, 2018.
• Following these transactions, Mr. Stein's indirect beneficial ownership of common stock is 8,158 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While a director selling shares can be seen as a negative, the transactions were pre-planned under a 10b5-1 plan, which mitigates concerns about opportunistic selling. The significant profit from option exercise highlights the company's stock performance and the value of its equity compensation program.

Positives

• The transactions were executed under a Rule 10b5-1 plan, indicating pre-planned sales not based on recent material non-public information, which enhances transparency.
• The significant difference between the option exercise price ($105.88) and the sale prices (ranging from $1,360.4385 to $1,362.431) demonstrates substantial value creation for the director from long-term equity incentives, reflecting positively on the company's stock performance.

Negatives

• A director selling shares, even under a 10b5-1 plan, reduces their direct equity exposure to the company, which some investors might perceive as a slight negative, though it is a common practice for diversification and liquidity.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• The shares are beneficially owned indirectly through the Fortuna Trust dated June 1, 2018, which is a related party to the reporting person.

Stakeholder Impact

• Shareholders may observe a director reducing their direct equity stake, which is a common practice for personal financial planning and diversification.
• The transactions demonstrate the effectiveness of equity compensation plans for management, aligning their interests with long-term shareholder value creation.

Key Dates

Recommendation

This Form 4 filing details routine, pre-planned insider transactions under a 10b5-1 plan. It shows a director exercising options and selling an equivalent number of shares, which is a common practice for liquidity and diversification. There are no new fundamental insights into the company's operations, financial health, or strategic direction that would warrant a change in investment recommendation based solely on this filing. Therefore, a 'hold' recommendation is appropriate as existing investment theses remain unchanged.

Keywords

TransDigm Group, TDG, Kevin Stein, Form 4, Insider Trading, Stock Options, Share Sale, 10b5-1 Plan, Director Transactions, Equity Compensation